Chimerix, Inc. Press Releases

Get CMRX Alerts
*Delayed - data as of Mar. 2, 2015  -  Find a broker to begin trading CMRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Chimerix to Announce Fourth Quarter and Year End 2014 Financial Results on March 6, 2015
2/27/2015 4:09:00 PM - GlobeNewswire

Chimerix Provides Update on Anticipated SUPPRESS Enrollment
2/26/2015 7:00:00 AM - GlobeNewswire

Chimerix to Present at the Cowen & Co. 35th Annual Health Care Conference
2/25/2015 1:11:00 PM - GlobeNewswire

Chimerix Presents Update on Preliminary Data From AdVise Study of Brincidofovir for Adenovirus Infection at BMT Tandem Meetings
2/12/2015 8:00:00 AM - GlobeNewswire

ContraVir Pharmaceuticals'' HBV Compound CMX157 Receives Extended Patent Life
2/4/2015 6:00:00 AM - PR Newswire

Chimerix Focusing Efforts on CMV and Adenovirus Pivotal Trials
1/30/2015 6:12:00 PM - GlobeNewswire

Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034
1/12/2015 8:30:00 AM - GlobeNewswire

Chimerix Provides Update on Brincidofovir Pivotal Phase 3 AdVise Trial for the Treatment of Adenovirus
1/8/2015 8:30:00 AM - GlobeNewswire

Biocept's Proprietary Oncology Diagnostics to be Offered on America's Choice Provider Network
1/7/2015 8:30:00 AM - GlobeNewswire

Chimerix to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/7/2015 8:30:00 AM - GlobeNewswire

Chimerix Provides Recap of 2014 Events
12/23/2014 8:30:00 AM - GlobeNewswire

Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12/18/2014 6:00:00 AM - GlobeNewswire

Chimerix Appoints Ronald C. Renaud, Jr. to Board of Directors
12/17/2014 4:30:00 PM - GlobeNewswire